MEETINGS - BIC (Germany) May 2008
This article was originally published in Clinica
Business in China, a "procurement summit" for European companies wishing to establish or expand their operations in China, will take place during May 28-29 2008 at the Berliner Congress Centre, Berlin, Germany. Among the industries included are medical technology, biotechnology and pharmaceuticals. Delegate numbers are restricted to 800 to ensure that bespoke agendas can be created and addressed for each attendee, says BIC. A conference will run concurrently to provide key aspects of conducting business in China and to highlight the business prospects of some of China's regions. For more information and to register, see: www.businesschinaexpo.com
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.